Contact us   |  

When is molecular analysis useful in MDS?

When is molecular analysis useful in MDS?

26/11/2020 17:00

Speakers: Valeria Santini

Target: Health professionals
Subnetworks: Myeloid malignancies

Valeria Santini is Associate Professor of Hematology at the University of Florence, Italy. She received her medical degree from the University of Florence and became a Consultant in Haematology. She worked as fellow of the European Organisation for Research and Treatment of Cancer (EORTC) at Dr Daniel den Hoed Cancer Center/Erasmus University, Rotterdam, The Netherlands. She then undertook clinical training in the USA at the Leukemia Unit, M. D. Anderson Cancer Center, University of Texas, Houston.

Professor Santini runs the MDS Unit- Hematology- Department of Experimental and Clinical Medicine- AOU Careggi, University of Florence. Her interests are focused on clinical and translational research in MDS and elderly AML.

Professor Santini is President of the Fondazione Italiana per lo studio delle sindromi mielodisplastiche (FISiM) and Italian Network of MDS Registries, a member of the Medical Advisory Board of the Aplastic Anemia and Myelodysplastic syndromes -International Foundation (AA & MDS IF), and member of the board of GIMEMA MDS working party. She is one of the 3 KOL for MDS working group in the European Harmony 2020 research project. She is a member of the Scientific Committee of the European School of Hematology (ESH), member of the Education Committee of the Society of Hematological Oncology (SOHO) and member of the Executive Board of the Scientific Working Group on MDS of European Hematology Association (EHA).  She has served for two terms on the executive board of the Italian Society of Haematology (SIE) and she has been Vice-president of the Italian Society of Experimental Haematology (SIES). She belongs to ASH, EHA and MDS Foundation. She is also an author of more than 200 peer-reviewed papers published in international journals, she is member of the Editorial board of Blood journal, and documented reviewer for high impact factor scientific journals. She has been an invited speaker at numerous international meetings including the American Society of Clinical Oncology (ASCO 2007: educational session on MDS), American Society of Hematology (ASH 2012, ASH 2016: educational sessions on MDS), European Haematology Association (EHA 2016, EHA 2020: Educational sessions on MDS) and national haematology societies of several countries.